Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Mol Biol Rep ; 47(8): 5985-5996, 2020 Aug.
Article in English | MEDLINE | ID: mdl-32780254

ABSTRACT

The aim of this study was to investigate the combination effect of exercise training and eugenol supplementation on the hippocampus apoptosis induced by CPF. 64 adult male albino rats were randomly selected and devided into eight groups of eight including: control, exercise (EXE), chlorpyrifos (CPF), Control + Oil (Co + Oil), Control + DMSO (Co + DMSO), chlorpyrifos + eugenol (CPF + Sup), chlorpyrifos + exercise (CPF + Exe) and, chlorpyrifos + exercise + eugenol (CPF + Exe + Eu). Four experimental groups received intraperitoneal injection (5 days a week) of 3.0 mg/kg body weight CPF in DMSO for 6 consecutive weeks. The exercise groups performed aerobic 5 days per week over 4 weeks. Eugenol were administered by gavage. Finally, the animals were sacrificed using CO2 gas (a half of the rats were anesthetized with ketamine and xylazine and then perfused) to evaluate hippocampus histology and parameters. The results of this study showed that CPF injection significantly decreased BDNF, AChE and ATP in CA1 area of the hippocampus (p ˂ 0.05). Also, CA1 apoptosis by tunnel assay, it was found that CPF receiving groups with different dosage, showed a significant increase compared to other groups, which was confirmed by increasing cytochrome C and procaspase-3 in CPF groups (p ˂ 0.05). The result of this study show that 4 weeks of exercise training and eugenol supplementation does not improve the destructive effects of CPF in CA1 area of the hippocampus. As a result, it is recommended that future studies longer periods for treatment with exercise and eugenol supplementation.


Subject(s)
Apoptosis/drug effects , Chlorpyrifos/toxicity , Eugenol/therapeutic use , Exercise Therapy , Hippocampus/drug effects , Organophosphate Poisoning/therapy , Physical Conditioning, Animal , Acetylcholinesterase/analysis , Adenosine Triphosphate/analysis , Animals , Avoidance Learning/drug effects , Brain-Derived Neurotrophic Factor/analysis , Caspase 3/analysis , Combined Modality Therapy , Cytochromes c/analysis , Disease Models, Animal , Eugenol/administration & dosage , Hippocampus/enzymology , Hippocampus/pathology , Male , Memory Disorders/chemically induced , Memory Disorders/drug therapy , Memory Disorders/pathology , Memory Disorders/therapy , Nerve Tissue Proteins/analysis , Organophosphate Poisoning/drug therapy , Random Allocation , Rats , Rats, Wistar
SELECTION OF CITATIONS
SEARCH DETAIL
...